Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
. Common Thyroid Disorders in Children Dr Sarar Mohamed FRCPCH (UK), MRCP (UK), CCST (Ire), CPT (Ire), DCH (Ire), MD Consultant Paediatric Endocrinologist & Metabolist Assistant Professor of Pediatrics King Saud University Endocrine Glands Agenda • • • • Thyroid Anatomy and physiology Thyroid Function Test Congenital Hypothyroidism Newborn screening for congenital hypothyroidism • Acquired hypothyroidism • Hyperthyroidism • Causes of goitre . Newborn Screening THYROID GLAND Location: Located close to thyroid cartilage. Has two lateral lobes connected by thyroid isthmus medially. Development: first endocrine gland to appear during development. Develops from endodermal floor of early pharynx THYROID GLAND Innervation: Vagus Nerve (X) Arterial Supply: superior thyroid artery (branch of external carotid artery). Functions: THYROXIN – regulate rate of metabolism CALCITONIN – decreases levels of calcium and phosphate in the blood (partially antagonistic to parathyroid hormone). Production of Thyroid Hormones NIS (Na+/I- Sympoter) TPO t1/2 = 5-7d t1/2 = < 24 hrs Normal Daily Thyroid Secretion Rate: T4 = 100 ug/day T3 = 6 ug/day ( ratio T4:T3 = 14:1 ) T4 Protein binding + 0.03% free T4 Protein binding + 0.3% free T3 85% (peripheral conversion) 15% T3 (10-20x less than T4) T4 T3 Potency 1 10 Protein Bound 10-20 1 Half-Life 5-7d < 24h Secreted by thyroid 100 ug/d 6 ug/d Thyroid Function: blood tests TSH mU/L Free T4 (thyroxine) pM Free T3 (triiodothyronine) 0.4 –5.0 9.1 – 23.8 2.23-5.3 pM Effects of thyroid hormones • • • • • • Fetal brain & skeletal maturation Increase in basal metabolic rate Inotropic & chronotropic effects on heart Stimulates gut motility Increase bone turnover Increase in serum glucose, decrease in serum cholesterol • Play role in thermal regulation Dysfunction Thyroid Gland 1. Too little thyroxin – hypothyroidism a. short stature (aquiered), developmental delay (congenital) 2. Too much thyroxin – hyperthyroidism a. Agitation, irritability, & weight loss Hypothyroidism • Decreased thyroid hormone levels • Low T4 • Possibly Low T3 too. • Raised TSH (unless pituitary problem!) . Causes of hypothyroidism • • • • • • • • Congenital Autoimmune (Hashimoto) Iodine deficiency Subacute thyroiditis Drugs (amiodarone) Irradiation Thyroid surgery Central hypothyroidism (radiotherapy, surgery, tumor) Clinical features of Acquired hypothyroidism • • • • • • • • • Weight gain Goitre Short sature Fatigue Constipation Dry skin Cold Intolerance Hoarseness Sinus Bradycardia . Hypothyroidism with short stature . Diagnosis • High TSH, low T4 • Thyroid antibodies Hashimoto’s Disease • Most common cause of hypothyroidism • Autoimmune lymphocytic thyroiditis • Antithyroid antibodies: • Thyroglobulin Ab • Microsomal Ab • TSH-R Ab (block) • Females > Males • Runs in Families! Subacute (de Quervain’s) Thyroiditis • • • • Preceding viral infection Infiltration of the gland with granulomas Painful goitre Hyperthyroid phase Hypothyroid phase Treatment of Hypothyroidism • Replacement thyroid hormone medication: Thyroxine . Congenital Hypothyroidism: Causes • • • • Agenesis or dysgenesis of thyroid gland Dyshormonogenesis Ectopic gland Maternal hypothyroidism Newborn Screening Facts Mother supplies T4 to fetus via placenta Normal Newborn Mother Fetus Immature Hypothalamic Pituitary Thyroid Axis T4 Mid-Gestation T4 Euthyroid Mother Mature Hypothalamic Pituitary Thyroid Axis Pregnancy Newborn Screening Clinical Features of Congenital Hypothyroidism Finding % Lethargy 96% Constipation 92% Feeding problems 83% Respiratory problems 76% Dry skin 76% Thick tongue 67% Hoarse cry 67% Umbilical hernia 67% Prolonged jaundice 12% Goiter 8% Newborn Screening Newborn Screening Congenital Hypothyroidism Clinical X suspect Biochemical (screening) Optional Confirm Lab ( TSH & FT4 ) T scan B age Rx & FU Thyroxine Growth & D TSH & FT4 Newborn Screening Management Primary Congenital Hypothyroidism High TSH & Low T4 Thyroxine Dose 10 -15 ug/kg/day 12 -17 ug/kg/day 37.5 – 50 ug/day Higher dose in Severe cases T4< 5ug/dl Form Goals Tablets Normal T4 In 2 wks (upper ½ of N) 25-50-75 ug Crush it, add to 5-10 cc water Or milk Normal TSH In one month (lower ½ of N) Newborn Screening Definitions Screening: search for a disease in a large unselected populatio PKU Congenital hypothyroidism Newborn Screening Principal of newborn screening • Aim is to identify affected infants before development of clinical signs Newborn Screening Success Stories in Pediatric Medicine Immunization programs Newborn Screening program Oral Rehydration Therapy Pencillin Newborn Screening Phenylketonuria Guthrie Test 1962, Robert Guthrie Newborn Screening Possible screening tests • • • • Glucose-6-phosphate dehydrogenase deficiency (G6PD) Sickle cell anemia (Hb SS) > 1 in 5,000; among African-Americans 1 in 400 Sickle-cell disease (Hb S/C) > 1 in 25,000 Hb S/Beta-Thalassemia (Hb S/Th) > 1 in 50,000 • • • • • • • • Tyrosinemia I (TYR I) < 1 in 100,000 Tyrosinemia II Argininemia Argininosuccinic aciduria (ASA) < 1 in 100,000 Citrullinemia (CIT) < 1 in 100,000 Phenylketonuria (PKU) > 1 in 25,000 Maple syrup urine disease (MSUD) < 1 in 100,000 Homocystinuria (HCY) < 1 in 100,000 • • • Glutaric acidemia type I (GA I) > 1 in 75,000 Glutaric acidemia type II HHH syndrome (Hyperammonemia, hyperornithinemia, homocitrullinuria syndrome) Hydroxymethylglutaryl lyase deficiency (HMG) < 1 in 100,000 Isovaleric acidemia (IVA) < 1 in 100,000 Isobutyryl-CoA dehydrogenase deficiency 2-Methylbutyryl-CoA dehydrogenase deficiency 3-Methylcrotonyl-CoA carboxylase deficiency > 1 in 75,000 Beta-methyl crotonyl carboxylase deficiency 3-Methylglutaconyl-CoA hydratase deficiency Methylmalonyl-CoA mutase deficiency (MUT) > 1 in 75,000 Methylmalonic aciduria, < 1 in 100,000 • • • • • • • • • • • • • Beta-ketothiolase deficiency (BKT) < 1 in 100,000 Propionic acidemia (PROP) > 1 in 75,000 Adenosylcobalamin synthesis defects Multiple-CoA carboxylase deficiency (MCD) < 1 in 100,000 • • • • • • • • • • • Carnitine palmityl transferase deficiency type 2 (CPT) Long-chain acyl-CoA dehydrogenase deficiency (LCAD) Long-chain hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) > 1 in 75,000 Short-chain acyl-CoA dehydrogenase deficiency (SCAD) Short-chain hydroxy Acyl-CoA dehydrogenase deficiency (SCHAD) Medium-chain acyl-CoA dehydrogenase deficiency (MCAD) > 1 in 25,000 Very-long-chain acyl-CoA dehydrogenase deficiency (VLCAD) > 1 in 75,000 Carnitine/acylcarnitine Translocase Deficiency (Translocase) Multiple acyl-CoA dehydrogenase deficiency (MADD) Trifunctional protein deficiency (TFP) < 1 in 100,000 Carnitine uptake defect (CUD) < 1 in 100,000 • • Congenital toxoplasmosis HIV • • Cystic fibrosis (CF) > 1 in 5,000 Maternal vitamin B12 deficiency • Congenital hypothyroidism (CH) > 1 in 4,000 • • • Biotinidase deficiency (BIOT) > 1 in 75,000 Congenital adrenal hyperplasia (CAH) > 1 in 25,000 Classical galactosemia (GALT) > 1 in 50,000 Newborn Screening Congenital Hypothyroid Screening started 1974 in Quebec & Pittsburgh Objective : Eradication of MR secondary to CH Incidence 1:3000 – 4000 ( more than PKU ) Female : Male is 2 : 1 Newborn Screening Congenital Hypothyroidism One of the most common Treatable causes of MR CH Screening is the most cost effective program Almost all affected NB have no S/S at birth Congenital Anomalies increased by 10%(cardiac) In more than 90% of the cases it is permanent The earlier dx the better IQ Newborn Screening Newborn Screening Criteria Wilson Criteria Congenital hypothyroidism Incidence >1/100,000 Significant morbidity/mortality Successful treatment Reasonable cost Test: specific/sensitive/acceptable 1/3,000 to 1/4,000 Mental retardation Thyroxine $3.00 immunoassay Newborn Screening Screening Technique • Specimen is a blood spot in a filter paper • Obtained by heel brick • Or cord blood Newborn Screening Newborn Screening Newborn Screening Good Specimen . Congenital Hypothyroidism Objective from screening: Eradication of MR secondary to CH Every Newborn is considered Hypothyroid Until Proven Otherwise Newborn Screening Method & Timing of Thyroid Screening Primary-TSH Backup-T4 Cord Blood Age At Birth Both TSH&T4 Primary-T4 Backup-TSH Venous Blood Age 2-5 days Newborn Screening Clinical Outcome • Pre-screening data: – Mean IQ = 76 Age of Diagnosis % with IQ > 85 3 months 78% 6 months 19% > 7 months 0% Newborn Screening Clinical Outcome • Post-screening data: – Children screened & treated by age 25 days • Mean IQ = 104 Newborn Screening > screening < screening Newborn Screening Congenital Hypothyroidism Hyperthyroidism • Increased thyroid hormone levels • High T4 +/- High T3 • Low (suppressed) TSH . Causes of hyperthroidism • • • • Graves Disease Overtreatment with thyroxine Thyroid adenoma (rare) Transient neonatal thyrotoxicosis Graves’ Disease • • • • Most common cause of hyperthyroidism Goitre, proptosis TSH-R antibody (stimulating) 40-70% relapse after 2 years of treatment Hyperthyroidism S&S • • • • • • • • • • • Heat intolerance Hyperactivity, irritability Weight loss (normal to increased appetite) diarrhea Tremor, Palpitations Diaphoresis (sweating) Lid retraction & Lid Lag (thyroid stare) proptosis menstrual irregularity Goitre Tachcardia Tremor of the hand A Color Atlas of Endocrinology p49 Neonatal hyperthyroidism born to mother with Graves’ disease A Color Atlas of Endocrinology p51 “Exophthalmos” Grave’s ophthalmopathy Hyperthyroid Eye Disease investigations • TSH, free T3&T4 • Thyroid antibodies (TSH receptors antibodies) • Radionucleotide thyroid scan (incease uptake) . Hyperthyroidism • Treatment – – – – – Beta-blockers Carbimazole PTU (propylthiouracil) Radioactive iodine (in adults) surgery . Causes of goitre • Congenital (maternal antithyroid drugs, maternal hyperthyroidism, dyshormonogenesis) • Physiological (puberty) • Iodine deficiency • Graves disease • Hashimoto thyroiditis • Tumor Goiter • A swollen thyroid gland Thank You! Newborn Screening